October 15, 2012
AGENDA
8:30 – 9:00 a.m. Registration & Light Breakfast
9:00 – 10:00 a.m.
NHLBI Panel
10:00 – 10:45 a.m.
Investor Perspectives Panel
10:45 – 11:00 a.m.
Coffee Break
11:00 a.m. – noon
Company Showcase
Noon – 1:00 p.m.
Networking Lunch
Gilchrist Hall Auditorium
Johns Hopkins University
9601 Medical Center Drive
Rockville, MD 20850
This conference brings together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries. It will feature presentations by top NHLBI SBIR- funded companies with innovative technologies on the brink of commercialization, an expert panel of investors, and opportunities for partnering and networking. Information about the NHLBI Office of Translational Alliances and Coordination, changes in the SBIR/STTR program re-authorization, and other funding opportunities and resources will be presented. NHLBI staff will be available to provide advice to applicants and awardees.
The NHLBI provides global leadership for research, training, and education to promote the prevention and treatment of heart, lung, blood, and sleep diseases and disorders and to enhance the health of allindividuals so that they can live longer and more fulfilling lives.
The investor perspectives panel will feature a distinguished panel of experts from the investor community, including representatives from NEA, Noble BioVentures, MedImmune and the Maryland Biotechnology Center.
The views expressed in these materials or by participants at the event do not necessarily reflect the official policies of the U.S. Department of Health and Human Services, the National Institutes of Health, or its components; nor does the inclusion of trade names/logos/trademarks or references to outside entities constitute or imply an endorsement by any Federal entity.